UBS Group’s Medovex Corp. Class A Warrant MDVXW Stock Holding History

UBS Group’s Portfolio MDVXW Stock Details MDVXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-953	Closed	–	–	8394
2017 Q3	$0	Buy	+953	New	+$169	﹤0.01%	8267
2017 Q2	–	Sell	-2,218	Closed	–	–	8295
2017 Q1	$0	Sell	2,218 -94	-4%	-$14	﹤0.01%	8298
2016 Q4	$0	Buy	2,312 +1,492	+182%	+$159	﹤0.01%	8304
2016 Q3	$0	Buy	820 +45	+6%	+$6	﹤0.01%	8184
2016 Q2	$0	Buy	775 +100	+15%	+$7	﹤0.01%	8192
2016 Q1	$0	Sell	675 -5,377	-89%	-$488	﹤0.01%	8574
2015 Q4	$0	Buy	+6,052	New	+$665	﹤0.01%	8753

UBS Group's MDVXW Position: Q4 2017 in Review

UBS Group sold out of Medovex Corp. Class A Warrant (MDVXW) in Q4 2017, closing a stake of 953 shares.

UBS Group first reported a position in MDVXW in Q4 2015 and held it in 7 quarters. The position peaked at $0 in Q3 2017. 0 funds tracked by Wall St. Rank hold MDVXW as of Q4 2017.

UBS Group reported no remaining Medovex Corp. Class A Warrant position as of Q4 2017 after selling out during the quarter.
UBS Group sold 953 Medovex Corp. Class A Warrant shares in Q4 2017.
UBS Group first reported a position in Medovex Corp. Class A Warrant in Q4 2015 and held it in 7 quarters.
UBS Group's Medovex Corp. Class A Warrant position peaked at $0 in Q3 2017.
0 funds tracked by Wall St. Rank held Medovex Corp. Class A Warrant as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.